<DOC>
	<DOC>NCT00002295</DOC>
	<brief_summary>To evaluate the effect of Isoprinosine in patients diagnosed as having AIDS relative to: Laboratory (immunologic defects): - Comparison of total helper and suppressor T-cell numbers among the groups. - Comparison of changes in natural killer cell activity. - Comparison of other laboratory findings among the groups. Clinical changes: - Comparison of the frequency of opportunistic infections among the groups. - Comparison of the frequency of the development of AIDS-related malignancies. - Comparison of other clinical manifestations relative to severity and time of onset.</brief_summary>
	<brief_title>A Study of Isoprinosine in Patients With Severe AIDS</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Inosine Pranobex</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition: Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer are excluded. Concurrent Medication: Excluded: Steroids. Cytotoxic immunosuppressive agents. Radiotherapy. The following are excluded: Critically ill patients. Patients receiving steroids, cytotoxic immunosuppressive agents, radiotherapy. Patients who have received any other immunotherapy. Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer. Prior Medication: Excluded: Any other immunotherapy. Patients with severe AIDS and specified laboratory immunologic defects.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 1989</verification_date>
	<keyword>Infusions, Intravenous</keyword>
	<keyword>Drug Evaluation</keyword>
	<keyword>Administration, Oral</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Biological Availability</keyword>
</DOC>